Authors


Harriette Canellos, OD, FAAO, Dipl ABO

Latest:

Meibomian gland dysfunction: At-home treatment devices

Warm compresses are an invaluable step in the treatment of dry eye.


Sonia Brujic, PharmD

Latest:

Know risks and benefits of ocular steroid use

Ophthalmic corticosteroids optimize outcomes in patients with ocular inflammatory conditions



Brian Pall, OD, MS, FAAO

Latest:

Transcript: First drug-eluting contact lens approved in Japan

Acuvue Theravision with Ketotifen from Johnson & Johnson Vision is the first entry into an anticipated category of drug-eluting contact lenses.


Eric Botts, OD

Latest:

Where to begin with dry eye technology

Adding laboratory testing and meibography helps patients and practices


Arthur Jung, OD

Latest:

5 reasons optometrists have failed to embrace myopia management

Some optometrists are reluctant to incorporate myopia control into practice. With global cases on the rise, the time to act is now.


Barbara M. Wirostko, MD, FARVO

Latest:

Fact or fiction? A closer look at management options

At-home devices challenge commonly held beliefs on IOP measurements, visual field testing, and imaging.


Hanne Hansen, OD

Latest:

Angle closure presentation differs

Cases illustrate how acute and chronic angle-closure glaucoma are treated


Erin Tomiyama, OD, PhD, FAAO

Latest:

Myopia: An epidemic of global proportions

As myopia prevalence continues to increase, there is a growing concern about myopia’s economic burden and effects on children, specifically on their visual impairment and quality of life. The consequences of myopia and high myopia can be delayed by implementing myopia management therapies.


Steven Leibowitz, MD

Latest:

Thyroid eye disease: The masquerading eye disorder— a guide to accurate diagnosis and collaborative care

In this episode, four expert faculty talk about the importance of early diagnosis and treatment of thyroid eye disease. They discuss the differential diagnosis, screening tests, and the need for multidisciplinary management for these patients.


Austin Lifferth, OD, FAAO

Latest:

All things glaucoma: A triad approach to evaluating the optic nerve, plus GlaucoMantras to carry with you

Austin Lifferth, OD, FAAO, shares highlights from his AAOpt 2022 presentations, including a triad approach to evaluating the optic nerve in glaucoma, and recentering glaucoma care with these 5 GlaucoMantras.


Heavin Maier, OD

Latest:

Contoured prism lenses enhance vision clarity and patient comfort

New technology improves precision of binocular vision disorder diagnosis and correction


Tracy Offerdahl, PHARMD, RPH, FAAO

Latest:

Biologic medications: The basics that every OD should know

This drug category is rapidly growing in the ophthalmic space, with more options in the pipeline


Sheri Rowen, MD, FACS, PCEO, FCWS

Latest:

Pearls for integrating dry eye disease management into your practice

Collaboration between ophthalmologists, optometrists can boost early detection.


Lotfi Merabet, OD, PhD, MPH

Latest:

Cerebral visual impairment

Documenting the visual effects and simplifying visual life.


Jeffrey Anshel, OD, FAAO

Latest:

The role of nutrition in myopia control

Studies suggest that high glycemic load carbohydrate diets may alter the genetic influence of growth of the sclera and choroid, which ultimately can induce permanent changes in the development and progression of myopia.



Lenna Walker OD, MS, FAAO

Latest:

Case report: OCT in the detection and diagnosis of neurofibromatosis type 1

Neurofibromatosis type 1 (NF1) is a condition associated with significant systemic morbidity. Abnormal proliferation of cells derived from the neural crest can cause benign and malignant tumors throughout the body in NF1.


Chris Maraboli

Latest:

Open Your Eyes documentary released on multiple platforms

Open Your Eyes documentary now available on Apple TV+ and Google Play!


Jay M. Haynie, OD, FAAO, FORS

Latest:

Victoria Conference 2023: Staying current with the AMD landscape

Jay M. Haynie, OD, FAAO, FORS, caught up with Peg Achenbach, OD, FAAO, while at the 2023 Victoria Conference to share highlights from his presentation on staying current with the AMD landscape.


Noor Chahal, BS

Latest:

Study finds significant variance across imaging modalities on sizes of geographic atrophy areas

A single, consistent modality leads to better geographic atrophy tracking.


Rhett Schiffman, MD, MHSA

Latest:

Transcript: Visus presbyopia drop gets FDA IND OK

A presbyopia-correcting eyedrop recently received FDA acceptance of its investigational new drug (IND) application


Heidi Sutter, OD, MPH

Latest:

Lessons learned from COVID-19: How to prepare for the next public health emergency

How eye care practices and doctors can prepare for the next pandemic


Sandeep Jain

Latest:

Telehealth success hinges on better tools

As the need for telemedicine increases, so does the urgency for creating new, less intrusive technology platforms.


Chris Kenrick, OD

Latest:

AAOpt 2022: The importance of perioperative management in corneal crosslinking

Chris Kenrick, OD, shares what she finds to be most important from her discussion this year at AAOpt 2022.


Jamie Ho, OD, FAAO, FCOVD

Latest:

SCOPA 2022: Low vision considerations, treatments, and tools

Jamie Ho, OD, FAAO, FCOVD, shares highlights from her SCOPA 2022 presentation, "Tools and considerations for low vision rehabilitation."


Essence Johnson, OD, FAAO

Latest:

NOA 2023: Dissecting the state of optometry

Essence Johnson, OD, FAAO, addressed the "State of optometry," at NOA 2023 in Fort Lauderdale, Florida.



Elana Meer, BA

Latest:

What the COVID-19 pandemic may mean for the power of electronic health records

Electronic health records may be the future of practice management.


Joshua Davidson, OD, FAAO, FSLS

Latest:

Agent improves near vision for irregular corneas with pinhole effect

Presbyopia-correcting drops for patients with low, up-close visual function.

© 2024 MJH Life Sciences

All rights reserved.